References
- Chapple CR, Khullar V, Gabriel Z, Muston D, Bittoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008; 54:543–562.
- Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61:37–49.
- Nilvebrant L, Andersson KE, Gillberg PG, Stahl M, Sparf B. Tolterodine—a new bladder-selective antimuscarinic agent. Eur J Pharmacol 1997; 327:195–207.
- Nilvebrant L, Hallén B, Larsson G. Tolterodine—a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data. Life Sci 1997; 60:1129–1136.
- Gil DW, Krauss HA, Bogardus AM, WoldeMussie E. Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation. Invest Ophthalmol Vis Sci 1997; 38:1434–1442.
- Swartz T, Marten L, Wang M. Measuring the cornea: the latest developments in corneal topography. Curr Opin Ophthalmol 2007; 18:325–333.
- O’Donnell C, Maldonado-Codina C. Agreement and repeatability of central corneal thickness measurement in normal corneas using ultrasound pachymetry and OCULUS Pentacam. Cornea 2005; 24:920–924.
- Altan-Yaycioglu R, Yaycioglu O, Akova YA, Guvel S, Ozkardes H. Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial. Br J Clin Pharmacol 2005; 59:588–592.
- Frischmeyer KJ, Miller PE, Bellay Y, Smedes SL, Brunson DB. Parenteral anticholinergics in dogs with normal and elevated intraocular pressure. Vet Surg 1993; 22:230–234.
- Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993; 3:335–348.
- Nelson CP, Gupta P, Napier CM, Nahorski SR, Challiss RA. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland. Pharmacol Exp Ther 2004; 310:1255–1265
- Kawasaki A, Moore P, Kardon RH. Long-term fluctuation of relative afferent pupillary defect in subjects with normal visual function. Am J Ophthalmol 1996; 122:875–882.